Literature DB >> 28069555

Self-assembled protein nanocarrier for intracellular delivery of antibody.

Sung In Lim1, Cyril I Lukianov1, Julie A Champion2.   

Abstract

Despite the great potential of antibodies as intracellular therapeutics, there is a significant, unmet challenge in delivering sufficient amounts of folded antibodies inside cells. We describe an all-protein self-assembled nanocarrier capable of delivering functional antibodies to the cytosol. By combining an α-helical peptide that self-assembles into a hexameric coiled-coil bundle and an Fc-binding Protein A fragment, we generated the Hex nanocarrier that is efficiently internalized by cells without cytotoxicity. Localization of multiple Fc-binding domains on the hexameric core allowed the Hex nanocarrier to tightly bind antibody with sub-nanomolar affinity regardless of pH and the antibody's originating species. The size of the Hex nanocarrier ranges from 25 to 35nm depending on the antibody loading ratio. We demonstrated the capacity of the Hex nanocarrier to deliver functional antibodies to the cytosol by employing anti-β-tubulin or anti-nuclear pore complex antibody as cargo. The design of the Hex nanocarrier is modular, which enables functionalization beyond Fc-binding. We exploited this feature to improve the cytosolic delivery efficiency of the Hex nanocarrier by addition of an endosomolytic motif to the core. The modified Hex nanocarrier exhibited similar antibody-binding behavior, but delivered more antibodies to their cytosolic targets at a faster rate. This work demonstrates an efficient intracellular antibody delivery platform with significant advantages over existing approaches as it does not require modification of the antibody, is biodegradable, and has an antibody to carrier mass ratio of 13, which is greater than other reported antibody carriers.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibody; Intracellular delivery; Protein nanocarrier; Self-assembly; Tubulin

Mesh:

Substances:

Year:  2017        PMID: 28069555     DOI: 10.1016/j.jconrel.2017.01.007

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  18 in total

1.  Gal8 Visualization of Endosome Disruption Predicts Carrier-Mediated Biologic Drug Intracellular Bioavailability.

Authors:  Kameron V Kilchrist; Somtochukwu C Dimobi; Meredith A Jackson; Brian C Evans; Thomas A Werfel; Eric A Dailing; Sean K Bedingfield; Isom B Kelly; Craig L Duvall
Journal:  ACS Nano       Date:  2019-01-18       Impact factor: 15.881

2.  Characterization and Control of Dynamic Rearrangement in a Self-Assembled Antibody Carrier.

Authors:  Anshul Dhankher; Manuel E Hernandez; Hannah C Howard; Julie A Champion
Journal:  Biomacromolecules       Date:  2020-03-05       Impact factor: 6.988

Review 3.  Nanoparticles for Manipulation of the Developmental Wnt, Hedgehog, and Notch Signaling Pathways in Cancer.

Authors:  D M Valcourt; M N Dang; J Wang; E S Day
Journal:  Ann Biomed Eng       Date:  2019-11-04       Impact factor: 3.934

4.  Conventional Nanosized Drug Delivery Systems for Cancer Applications.

Authors:  Cristian Vergallo; Muhammad Nadeem Hafeez; Dalila Iannotta; Hélder A Santos; Nicola D'Avanzo; Luciana Dini; Felisa Cilurzo; Massimo Fresta; Luisa Di Marzio; Celia Christian
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Antibody Nanocarriers for Cancer Management.

Authors:  Megan N Dang; Elise C Hoover; Mackenzie A Scully; Eric H Sterin; Emily S Day
Journal:  Curr Opin Biomed Eng       Date:  2021-05-26

6.  Synergistic Interplay of Covalent and Non-Covalent Interactions in Reactive Polymer Nanoassembly Facilitates Intracellular Delivery of Antibodies.

Authors:  Kingshuk Dutta; Pintu Kanjilal; Ritam Das; Sankaran Thayumanavan
Journal:  Angew Chem Int Ed Engl       Date:  2020-11-19       Impact factor: 15.336

7.  Demonstration of intracellular trafficking, cytosolic bioavailability, and target manipulation of an antibody delivery platform.

Authors:  Wei Lv; Julie A Champion
Journal:  Nanomedicine       Date:  2020-10-13       Impact factor: 5.307

8.  Protein Based Biomaterials for Therapeutic and Diagnostic Applications.

Authors:  Stanley Chu; Andrew L Wang; Aparajita Bhattacharya; Jin Kim Montclare
Journal:  Prog Biomed Eng (Bristol)       Date:  2021-10-26

9.  Coiled coil exposure and histidine tags drive function of an intracellular protein drug carrier.

Authors:  Anshul Dhankher; Wei Lv; William T Studstill; Julie A Champion
Journal:  J Control Release       Date:  2021-09-24       Impact factor: 9.776

10.  Designed proteins assemble antibodies into modular nanocages.

Authors:  Robby Divine; Ha V Dang; George Ueda; Jorge A Fallas; Ivan Vulovic; William Sheffler; Shally Saini; Yan Ting Zhao; Infencia Xavier Raj; Peter A Morawski; Madeleine F Jennewein; Leah J Homad; Yu-Hsin Wan; Marti R Tooley; Franziska Seeger; Ali Etemadi; Mitchell L Fahning; James Lazarovits; Alex Roederer; Alexandra C Walls; Lance Stewart; Mohammadali Mazloomi; Neil P King; Daniel J Campbell; Andrew T McGuire; Leonidas Stamatatos; Hannele Ruohola-Baker; Julie Mathieu; David Veesler; David Baker
Journal:  Science       Date:  2021-04-02       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.